Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could—if given early enough—potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection.
Clinical Trial of Blood Pressure Drug Aimed at Preventing Lethal Complication of COVID-19
- by Clinton
- Uncategorized
Tags:Blood PressureCoronavirusCOVID-19Johns Hopkins Kimmel Cancer CenterLudwig CenterResearchSARS-CoV-2